The key to treating rare liver cancer may lie in immunotherapy directed against the cancer fusion protein.

Published Date: 20 Mar 2024

If surgery is not performed quickly to treat fibrolamellar carcinoma (FLC), a rare form of liver cancer, the prognosis is not good. One single genetic mutation that results in the production of a fusion protein is the cause of the illness. researchers at St. Jude Youth Foundation.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Reducing social media to an hour a day boosts young people's self-image.

2.

Omicron Infections Are Usually Cleared Up in Immunocompromised Patients.

3.

The pandemic had little impact on mental health symptoms.

4.

FDA Approves New Bladder Cancer First-Line Standard of Care.

5.

A higher risk of chemotherapy-induced peripheral neuropathy is associated with a deficiency in vitamin D prior to treatment.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot